deltatrials
Completed NA INTERVENTIONAL 2-arm NCT05134545

Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease

A Multicenter, Prospective, Randomized, Double-blind, Pivotal Clinical Study to Evaluate the Effectiveness and Safety of GENOSS® DCB Versus IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease of Femoral and Popliteal Artery

Sponsor: Genoss Co., Ltd.

Conditions De Novo Stenosis Peripheral Artery Disease
Interventions Genoss® DCB IN.PACT Admiral® DCB
Updated 8 times since 2021 Last updated: Aug 21, 2024 Started: Mar 24, 2019 Primary completion: Dec 30, 2022 Completion: Jun 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates De Novo Stenosis and Peripheral Artery Disease and is currently completed. Genoss Co., Ltd. leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshotRecruiting~Mar 2022 – ~Mar 2023 · 12 months · monthly snapshotRecruiting~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshotActive Not Recruiting~Apr 2023 – ~Oct 2023 · 6 months · monthly snapshotActive Not Recruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Oct 2023 — Jul 2024 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  5. Apr 2023 — Oct 2023 [monthly]

    Active Not Recruiting NA

▶ Show 3 earlier versions

  1. Mar 2023 — Apr 2023 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  2. Mar 2022 — Mar 2023 [monthly]

    Recruiting NA

  3. Dec 2021 — Mar 2022 [monthly]

    Recruiting NA

    First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Genoss Co., Ltd.
Data source: Genoss Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations